Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00589563 · OUTCOME

Severity of Chronic GVHD

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer · Source last updated 2014-09-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Patients were evaluated until they developed chronic GVHD, a median of 130 days post HSCT

What was measured

All Patients were considered for the evaluation of chronic GVHD severity.

Groups in this outcome

All Patients

All patients were analyzed as a single population. Stratification by conditioning regimen was not done.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients32

Reported measurements

No Chronic GVHD
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients4Not reportedNot reportedNot reportedNot reported
Yes- Limited
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients4Not reportedNot reportedNot reportedNot reported
Yes - Extensive
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients17Not reportedNot reportedNot reportedNot reported
No- Inevaluable (graft failure/died <day 100)
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients7Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        4
    title
    No Chronic GVHD
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        4
    title
    Yes- Limited
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        17
    title
    Yes - Extensive
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        7
    title
    No- Inevaluable (graft failure/died <day 100)
denoms
  1. counts
    1. group Id
      OG000
      value
      32
    units
    Participants
description
All Patients were considered for the evaluation of chronic GVHD severity.
groups
  1. description
    All patients were analyzed as a single population. Stratification by conditioning regimen was not done.
    id
    OG000
    title
    All Patients
param Type
NUMBER
reporting Status
POSTED
time Frame
Patients were evaluated until they developed chronic GVHD, a median of 130 days post HSCT
title
Severity of Chronic GVHD
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice